Risk Factors for a Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infection: A Five-Year Retrospective Study

References

• van Duijn PJ, Dautzenberg MJ, Oostdijk EA. Recent trends in antibiotic resistance in European ICUs. Curr Opin Crit Care. 2011;17(6):658–665. doi:10.1097/MCC.0b013e32834c9d87
   PubMed Web of Science ®Google Scholar
• Hu F, Zhu D, Wang F, et al. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–s134. doi:10.1093/cid/ciy657
   PubMed Web of Science ®Google Scholar
• Humphries RM, Yang S, Kim S, et al. Duodenoscope-related outbreak of a carbapenem-resistant Klebsiella pneumoniae identified using advanced molecular diagnostics. Clin Infect Dis. 2017;65(7):1159–1166. doi:10.1093/cid/cix527
   PubMed Web of Science ®Google Scholar
• Nordmann P, Poirel L. Epidemiology and diagnostics of carbapenem resistance in gram-negative bacteria. Clin Infect Dis. 2019;69(Suppl 7):S521–s528. doi:10.1093/cid/ciz824
   PubMed Web of Science ®Google Scholar
• David S, Reuter S, Harris SR, et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nature Microbiol. 2019;4(11):1919–1929. doi:10.1038/s41564-019-0492-8
   Web of Science ®Google Scholar
• Zong Z, Wu A, Hu B. Infection control in the era of antimicrobial resistance in china: progress, challenges, and opportunities. Clin Infect Dis. 2020;71(Suppl 4):S372–s378. doi:10.1093/cid/ciaa1514
   PubMed Web of Science ®Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-1
   PubMed Web of Science ®Google Scholar
• Guh AY, Bulens SN, Mu Y, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012–2013. JAMA. 2015;314(14):1479–1487. doi:10.1001/jama.2015.12480
   PubMed Web of Science ®Google Scholar
• Guh AY, Limbago BM, Kallen AJ. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti Infect Ther. 2014;12(5):565–580. doi:10.1586/14787210.2014.902306
   PubMed Web of Science ®Google Scholar
• Ben-David D, Kordevani R, Keller N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54–60. doi:10.1111/j.1469-0691.2011.03478.x
   PubMed Web of Science ®Google Scholar
• Xu L, Sun X, Ma X. Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae. Ann Clin Microbiol Antimicrob. 2017;16(1):18. doi:10.1186/s12941-017-0191-3
   PubMed Web of Science ®Google Scholar
• Markwart R, Saito H, Harder T, et al. Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1536–1551. doi:10.1007/s00134-020-06106-2
   PubMed Web of Science ®Google Scholar
• Fleischmann-Struzek C, Mikolajetz A, Schwarzkopf D, et al. Challenges in assessing the burden of sepsis and understanding the inequalities of sepsis outcomes between National Health Systems: secular trends in sepsis and infection incidence and mortality in Germany. Intensive Care Med. 2018;44(11):1826–1835. doi:10.1007/s00134-018-5377-4
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhu M, Li C, et al. Epidemiology and microbiology of Gram-negative bloodstream infections in a tertiary-care hospital in Beijing, China: a 9-year retrospective study. Expert Rev Anti Infect Ther. 2021;19(6):769–776. doi:10.1080/14787210.2021.1848544
   PubMed Web of Science ®Google Scholar
• Mitchell E, Pearce MS, Roberts A. Gram-negative bloodstream infections and sepsis: risk factors, screening tools and surveillance. Br Med Bull. 2019;132(1):5–15. doi:10.1093/bmb/ldz033
   Web of Science ®Google Scholar
• Stewardson AJ, Marimuthu K, Sengupta S, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019;19(6):601–610. doi:10.1016/S1473-3099(18)30792-8
   PubMed Web of Science ®Google Scholar
• Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52(3):1028–1033. doi:10.1128/AAC.01020-07
   PubMed Web of Science ®Google Scholar
• Fasciana T, Ciammaruconi A, Gentile B, et al. Draft genome sequence and biofilm production of a carbapenemase-producing Klebsiella pneumoniae (KpR405) sequence type 405 strain isolated in Italy. Antibiotics. 2021;10(5):560.
   Web of Science ®Google Scholar
• Wiener-Well Y, Rudensky B, Yinnon AM, et al. Carriage rate of carbapenem-resistant Klebsiella pneumoniae in hospitalised patients during a national outbreak. J Hosp Infect. 2010;74(4):344–349. doi:10.1016/j.jhin.2009.07.022
   PubMed Web of Science ®Google Scholar
• Yan L, Sun J, Xu X, et al. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital. Antimicrob Resist Infect Control. 2020;9(1):155. doi:10.1186/s13756-020-00816-4
   Web of Science ®Google Scholar
• Glisovic S, Eintracht S, Longtin Y, et al. Rectal swab screening assays of public health importance in molecular diagnostics: sample adequacy control. J Infect Public Health. 2018;11(2):234–237. doi:10.1016/j.jiph.2017.07.009
   Web of Science ®Google Scholar
• Lledo W, Hernandez M, Lopez Eet al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortal Wkly Rep. 2009;58(10):256–260.
   PubMedGoogle Scholar
• Borer A, Eskira S, Nativ R, et al. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel. Infect Control Hosp Epidemiol. 2011;32(12):1158–1165. doi:10.1086/662620
   Web of Science ®Google Scholar
• Ghafur A, Nagvekar V, Thilakavathy S, et al. “Save Antibiotics, Save lives”: an Indian success story of infection control through persuasive diplomacy. Antimicrob Resist Infect Control. 2012;1(1):29. doi:10.1186/2047-2994-1-29
   PubMed Web of Science ®Google Scholar
• Giacobbe DR, Del Bono V, Mikulska M, et al. Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy. Infection. 2017;45(6):849–856. doi:10.1007/s15010-017-1063-7
   PubMed Web of Science ®Google Scholar
• Bogan C, Marchaim D. The role of antimicrobial stewardship in curbing carbapenem resistance. Future Microbiol. 2013;8(8):979–991. doi:10.2217/fmb.13.73
   Web of Science ®Google Scholar
• Martin J, Phan HTT, Findlay J, et al. Covert dissemination of carbapenemase-producing Klebsiella pneumoniae (KPC) in a successfully controlled outbreak: long- and short-read whole-genome sequencing demonstrate multiple genetic modes of transmission. J Antimicrob Chemother. 2017;72(11):3025–3034. doi:10.1093/jac/dkx264
   PubMed Web of Science ®Google Scholar
• Redder JD, Leth RA, Møller JK. Analysing risk factors for urinary tract infection based on automated monitoring of hospital-acquired infection. J Hosp Infect. 2016;92(4):397–400. doi:10.1016/j.jhin.2015.12.009
   Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Zhang P, Wang J, Hu H, et al. Clinical characteristics and risk factors for bloodstream infection due to carbapenem-resistant Klebsiella pneumoniae in patients with hematologic malignancies. Infect Drug Resist. 2020;13:3233–3242.
   Web of Science ®Google Scholar
• Di Gaudio F, Indelicato S, Indelicato S, et al. Improvement of a rapid direct blood culture microbial identification protocol using MALDI-TOF MS and performance comparison with SepsiTyper kit. J Microbiol Methods. 2018;155:1–7.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Third Informational Supplement, M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.
   Google Scholar
• Vaquero-Herrero MP, Ragozzino S, Castaño-Romero F, et al. The Pitt bacteremia score, Charlson comorbidity index and chronic disease score are useful tools for the prediction of mortality in patients with Candida bloodstream infection. Mycoses. 2017;60(10):676–685. doi:10.1111/myc.12644
   Web of Science ®Google Scholar
• Watson D, Spaulding AB, Dreyfus J. Risk-set matching to assess the impact of hospital-acquired bloodstream infections. Am J Epidemiol. 2019;188(2):461–466. doi:10.1093/aje/kwy252
   Web of Science ®Google Scholar
• Pitout JD, Nordmann P, Poirel L. Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother. 2015;59(10):5873–5884. doi:10.1128/AAC.01019-15
   PubMed Web of Science ®Google Scholar
• Kaye KS, Bhowmick T, Metallidis S, et al. Effect of meropenem-vaborbactam vs piperacillin-tazobactam on clinical cure or improvement and microbial eradication in complicated urinary tract infection: the TANGO I randomized clinical trial. JAMA. 2018;319(8):788–799. doi:10.1001/jama.2018.0438
   PubMed Web of Science ®Google Scholar
• Kim SW, Yoon JS, Park J, et al. Empirical treatment with carbapenem vs third-generation cephalosporin for treatment of spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2021;19(5):976–986.e975. doi:10.1016/j.cgh.2020.06.046
   Web of Science ®Google Scholar
• Xiao T, Zhu Y, Zhang S, et al. A retrospective analysis of risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae bacteremia in nontransplant patients. J Infect Dis. 2020;221(Suppl 2):S174–s183. doi:10.1093/infdis/jiz559
   PubMed Web of Science ®Google Scholar
• Hsu JY, Chuang YC, Wang JT, et al. Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: risk factors, mortality, and antimicrobial susceptibility, 2017–2019. J Formosan Med Assoc. 2021;120:1994–2002. doi:10.1016/j.jfma.2021.04.014
   PubMed Web of Science ®Google Scholar
• Qin X, Wu S, Hao M, et al. The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China. J Infect Dis. 2020;221(Suppl 2):S206–s214. doi:10.1093/infdis/jiz622
   PubMed Web of Science ®Google Scholar
• Zhang H, Liang B, Wang J, et al. Non-carbapenem β-lactam/β-lactamase inhibitors versus carbapenems for urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae: a systematic review. Int J Antimicrob Agents. 2021;58(4):106410. doi:10.1016/j.ijantimicag.2021.106410
   Web of Science ®Google Scholar
• Dong Y, Li Y, Zhang Y, et al. Clinical efficacy and cost-effectiveness of β-Lactam/β-Lactamase inhibitor combinations and carbapenems in liver cirrhosis patients with gram-negative bacteria bloodstream infection. Infect Drug Resist. 2020;13:1327–1338. doi:10.2147/IDR.S241648
   Web of Science ®Google Scholar
• Harris PNA, Tambyah PA, Lye DC, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984–994. doi:10.1001/jama.2018.12163
   PubMed Web of Science ®Google Scholar
• Landman D, Babu E, Shah N, et al. Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother. 2012;67(6):1427–1431. doi:10.1093/jac/dks063
   PubMed Web of Science ®Google Scholar
• Adams DJ, Susi A, Nylund CM. Clinical characteristics, risk factors, and outcomes of patients hospitalized in the US military health system with carbapenem-resistant Enterobacteriaceae infection. Am J Infect Control. 2020;48(6):644–649. doi:10.1016/j.ajic.2019.10.006
   Web of Science ®Google Scholar
• Parm Ü, Metsvaht T, Sepp E, et al. Mucosal surveillance cultures in predicting Gram-negative late-onset sepsis in neonatal intensive care units. J Hosp Infect. 2011;78(4):327–332. doi:10.1016/j.jhin.2011.03.025
   Web of Science ®Google Scholar
• Guilhen C, Miquel S, Charbonnel N, et al. Colonization and immune modulation properties of Klebsiella pneumoniae biofilm-dispersed cells. NPJ Biofilms Microbiomes. 2019;5(1):25. doi:10.1038/s41522-019-0098-1
   Web of Science ®Google Scholar
• Parm U, Metsvaht T, Sepp E, et al. Risk factors associated with gut and nasopharyngeal colonization by common Gram-negative species and yeasts in neonatal intensive care units patients. Early Hum Dev. 2011;87(6):391–399. doi:10.1016/j.earlhumdev.2011.02.007
   Web of Science ®Google Scholar
• Kontopoulou K, Iosifidis E, Antoniadou E, et al. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection. J Med Microbiol. 2019;68(3):326–335. doi:10.1099/jmm.0.000921
   PubMed Web of Science ®Google Scholar
• Souverein D, Euser SM, Herpers BL, et al. Association between rectal colonization with highly resistant gram-negative rods (HR-GNRs) and subsequent infection with HR-GNRs in clinical patients: a one year historical cohort study. PLoS One. 2019;14(1):e0211016. doi:10.1371/journal.pone.0211016
   Web of Science ®Google Scholar
• Strich JR, Warner S, Lai YL, et al. Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study. Lancet Infect Dis. 2020;20(10):1172–1181. doi:10.1016/S1473-3099(20)30153-5
   PubMed Web of Science ®Google Scholar
• Kim YA, Lee SJ, Park YS, et al. Risk factors for carbapenemase-producing enterobacterales infection or colonization in a Korean Intensive Care Unit: a Case-Control Study. Antibiotics. 2020;9(10). doi:10.3390/antibiotics9100680
   Web of Science ®Google Scholar
• Akgul F, Bozkurt I, Sunbul M, et al. Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study. Pathog Glob Health. 2016;110(7–8):321–325. doi:10.1080/20477724.2016.1254976
   PubMed Web of Science ®Google Scholar
• Zhao GJ, Li D, Zhao Q, et al. Incidence, risk factors and impact on outcomes of secondary infection in patients with septic shock: an 8-year retrospective study. Sci Rep. 2016;6:38361. doi:10.1038/srep38361
   PubMed Web of Science ®Google Scholar
• Doi Y. Treatment options for carbapenem-resistant gram-negative bacterial infections. Clin Infect Dis. 2019;69(Suppl 7):S565–s575. doi:10.1093/cid/ciz830
   PubMed Web of Science ®Google Scholar
• Gonzalez-Padilla M, Torre-Cisneros J, Rivera-Espinar F, et al. Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae. J Antimicrob Chemother. 2015;70(3):905–913. doi:10.1093/jac/dku432
   PubMed Web of Science ®Google Scholar
• Loose M, Link I, Naber KG, et al. Carbapenem-containing combination antibiotic therapy against carbapenem-resistant uropathogenic Enterobacteriaceae. Antimicrob Agents Chemother. 2019;64(1). doi:10.1128/AAC.01839-19
   Web of Science ®Google Scholar
• Li J, Bi W, Dong G, et al. The new perspective of old antibiotic: in vitro antibacterial activity of TMP-SMZ against Klebsiella pneumoniae. J Microbiol Immunol Infect. 2020;53(5):757–765. doi:10.1016/j.jmii.2018.12.013
   Google Scholar
• Koppe U, von Laer A, Kroll LE, et al. Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German Antimicrobial Resistance Surveillance (ARS). Antimicrob Resist Infect Control. 2018;7:71. doi:10.1186/s13756-018-0362-9
   Web of Science ®Google Scholar
• Cusini A, Herren D, Bütikofer L, et al. Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae: a retrospective observational study. Antimicrob Resist Infect Control. 2018;7:89. doi:10.1186/s13756-018-0387-0
   Web of Science ®Google Scholar
• Pogue JM, Neelakanta A, Mynatt RP, et al. Carbapenem-resistance in gram-negative bacilli and intravenous minocycline: an antimicrobial stewardship approach at the Detroit Medical Center. Clin Infect Dis. 2014;59(Suppl 6):S388–393. doi:10.1093/cid/ciu594
   PubMed Web of Science ®Google Scholar
• Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a longitudinal large-scale CRE Study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–s205. doi:10.1093/cid/ciy660
   PubMed Web of Science ®Google Scholar
• Zhao C, Wistrand-Yuen P, Lagerbäck P, et al. Combination of polymyxin B and minocycline against multidrug-resistant Klebsiella pneumoniae: interaction quantified by pharmacokinetic/pharmacodynamic modelling from in vitro data. Int J Antimicrob Agents. 2020;55(6):105941. doi:10.1016/j.ijantimicag.2020.105941
   PubMed Web of Science ®Google Scholar
• Yamaguchi RS, Noritomi DT, Degaspare NV, et al. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis. Intensive Care Med. 2017;43(8):1097–1104. doi:10.1007/s00134-017-4852-7
   Web of Science ®Google Scholar
• Bonizzoli M, Batacchi S, Cianchi G, et al. Peripherally inserted central venous catheters and central venous catheters related thrombosis in post-critical patients. Intensive Care Med. 2011;37(2):284–289. doi:10.1007/s00134-010-2043-x
   PubMed Web of Science ®Google Scholar
• Reunes S, Rombaut V, Vogelaers D, et al. Risk factors and mortality for nosocomial bloodstream infections in elderly patients. Eur J Intern Med. 2011;22(5):e39–44. doi:10.1016/j.ejim.2011.02.004
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang Z, Sun L, et al. Clinical observation and prognostic analysis of patients with Klebsiella pneumoniae bloodstream infection. Front Cell Infect Microbiol. 2020;10:577244. doi:10.3389/fcimb.2020.577244
   PubMed Web of Science ®Google Scholar
• Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28(6):1871–1876. doi:10.1097/00003246-200006000-00031
   PubMed Web of Science ®Google Scholar
• Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117(2):163–168. doi:10.1161/CIRCULATIONAHA.107.727545
   PubMed Web of Science ®Google Scholar
• Hu ZD, Lippi G, Montagnana M. Diagnostic and prognostic value of red blood cell distribution width in sepsis: a narrative review. Clin Biochem. 2020;77:1–6. doi:10.1016/j.clinbiochem.2020.01.001
   PubMed Web of Science ®Google Scholar